IBO - IMPACT BIOMEDICAL INC.
0.4951
-0.015 -3.009%
Share volume: 1,179,138
Last Updated: 04-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.14%
PREVIOUS CLOSE
CHG
CHG%
$0.51
-0.01
-0.03%
View ratios
| Fiscal Date | 12-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q4 2024 | |
| Report Date | 03-28-2025 | |
| Total revenue | 0.000 | |
| Cost of revenue | 0.000 | |
| Gross profit | 0.000 | |
| Operating expenses | 432.000 K | |
| Selling general and admin | 286.000 K | |
| Research and development | 146.000 K | |
| Total expenses | 26.229 M | |
| Operating income | -26.229 M | |
| Ebit | -26.831 M | |
| Pretax income | -27.096 M | |
| Income tax | 33.000 K | |
| Net income basic | 0.000 | |
| Net income | -27.129 M | |
